AI assistant
Sending…
MUSTANG BIO, INC. — Director's Dealing 2017
Jul 21, 2017
35167_dirs_2017-07-20_caf952b3-7702-4e9b-8e6a-2ea524db5ba9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MUSTANG BIO, INC. (NONE)
CIK: 0001680048
Period of Report: 2016-09-26
Reporting Person: ROSENWALD LINDSAY A MD (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (Restricted) | 10000 | Direct |
Footnotes
F1: The 10,000 shares are restricted common stock, which will vest on 6/30/2020, subject to Dr. Rosenwald's continued service on the board on such date.
More from MUSTANG BIO, INC.
Interim / Quarterly Report
2026
May 5
Delisting Announcement
2026
Apr 17
Major Shareholding Notification
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Proxy Solicitation & Information Statement
2025
Dec 3
Interim / Quarterly Report
2025
Nov 7